Sequence analysis of the haemagglutinin protein (H) gene of the morbillivirus (PDV-2) isolated from a Siberian seal (Phoca sibirica) during the 1987/ 1988 epizootic in Lake Baikal revealed that it was most closely related to two recent isolates of canine distemper virus (CDV) from Germany and different from CDV vaccines currently in use in that region. The virus continued to circulate in seals in Lake Baikal after the 1987/ 1988 epizootic since sera collected from culled seals in the spring of 1992 were positive in morbillivirus ELISA tests, reacting most strongly with the CDV antigen.
Introduction
The Morbilliviruses constitute an antigenically related genus within the Paramyxoviridae. In addition to canine distemper (CDV) which infects Canidae and Mustelidae and other carnivores (see Appel, 1987; Appel and Summers, 1995) , the genus also includes measles virus (MV) which infects humans and other primates, rinderpest virus (RPV) which infects cattle and other large ruminants, and peste des petits ruminants virus (PPRV) which infects sheep, goats and other small ruminants. The virus epizootic which occurred in seals in Northern Europe during the summer and autumn of 1988 was caused by a morbillivirus closely related to, but distinct from, CDV (Osterhaus and Vedder, 1988; Mahy et al., 1988; Haas et al., 1991) . A similar disease was seen in seals in Lake Baikal, Siberia, in December 1987, sometime earlier than the European epizootic Likhoshway et al., 1989; Osterhaus et al., 1989a, b; Titer&o et al., 1990) . There was no obvious epidemiological link between the outbreak in marine seals in Europe and that in freshwater seals in Lake Baikal several thousand kilometers distant. Subsequent monoclonal antibody and RT/PCR studies established that the European and Siberian seal isolates were quite different from each other and that the Siberian isolate is very similar to CDV (Osterhaus et al., 1989a; Visser et al., 1990; Barrett et al., 1992) . The virus isolated from European seals is referred to as 'phocid distemper virus-1 (PDV-1) ' and that isolated from Siberian seals as 'phocid distemper virus-2 (PDV-2)' (Visser et al., 1990) .
CDV is known to infect a wide range of carnivore species and, since the live attenuated vaccines currently in use are not attenuated for wildlife species (Carpenter et al., 1976) ) it was possible that the infection in Baikal seals was caused by a vaccine strain of the virus widely used in domestic dogs and on mink farms in Siberia. In this paper we provide evidence, based on sequence data derived from the haemagglutinin protein (H) gene, that a wild-type virus was responsible for the epizootic and serological evidence that the virus continued to circulate in Baikal seals after 1988.
Materials and methods

Cells and viruses
The following CDV virus isolates were studied: two recent German field viruses isolated from a dog and a ferret (Harder et al., 1993) and the virus (PDV-2) isolated from a Siberian seal during the epizootic in 1988 (Visser et al., 1990) . All viruses were grown on Vero cells and RNA was prepared from the infected cells when extensive cpe was evident using the method described by Chomczynski and Sacchi ( 1987) .
DNA cloning
The cDNA synthesis and amplification reactions were carried out on total RNA derived from tissue culture grown virus as previously described (Haas et al., 1991) . The CDVspecific RNA was amplified by PCR using a primer set based on the first and last 20 nucleotides of the CDV H gene sequence published by (Curran et al., 1991) . The PCRderived DNA of the expected size was purified on low melting point agarose and cloned into the pT7 Blue PCR vector as described by the suppliers (Applied Biosystems, U.K. Ltd) .
Sequence analysis
The resulting recombinant plasmids carrying CDV H gene inserts were sequenced using the Ml3 universal forward and reverse primers as described by Murphy and Kavanagh ( 1988) and by direct sequencing of the PCR product using labelled primers (Murray, 1989) .
ELISA
The antigen used to coat the 96-well microtitre plates (Nunc Maxisorp, Denmark) was prepared from infected vero cells exhibiting extensive CPE using sucrose density gradient purification (Barrett et al., 1989) . The antigen was diluted to a concentration of 10 pg/ml in phosphate-buffered saline (PBS; 135 mM NaCl, 26 mM KCl, 3 mM CaCl,, 5 mM MgC12, 70 mM NaHP04, KH2PO,, pH 7.4)) and incubated for one hour at 37°C. The plates were washed with PBS and incubated for one hour at 37°C with seal sera diluted in blocking buffer (PBS containing 0.1% Tween 20 and 3% bovine serum albumin). After further washing horseradish-peroxidase conjugated protein A (Flow laboratories) was used as the second antibody diluted in blocking buffer and incubated as before. After a final wash substrate was added (o-phenylenediamine dihydrochloride, Sigma) and optical density taken at 492 nm. A positive response was deemed to be one that was greater than twice the background of the negative control serum.
Results
Haemagglutinin gene sequences
At the nucleotide sequence level, PDV-2 was approximately 95% identical to the dog and ferret isolates but only 92% to the Onderstepoort vaccine. The H sequences of the two vaccine strains of CDV (Onderstepoort and Convac) available on the database are 99.9% identical to each other. The nucleotide sequence data have been submitted to the EMBL database (access numbers: PDV-2: X84998; Ferret virus: X84999; Dog virus: X85000). The sequences of the various CDV isolates were subjected to pairwise sequence comparisons using the PHYLIP DNADIST program (Felsenstein, 1989) . The Siberian virus PDV-2 was found to be more closely related to the two German field isolates than to the Onderstepoort vaccine when compared using either the KITCH or FITCH phylogenetic programs (see Fig. 1 , panels a and b) . All CDV sequences were quite distinct from PDV-1 with an identity of approximately 70%.
The deduced amino acid sequences are presented in Fig. 2 , aligned with the published CDV Onderstepoort vaccine strain. There were many scattered single amino acid changes when all proteins were compared but no clusers of amino acid changes which would indicate a site in the protein which was subject to antigenic pressure. Again the percentage identity of PDV-2 compared to the German isolates was approximately 95% but was only 89% identical to the vaccine strain. When conservative amino acid substitutions were taken into account the figures rose to 97% and 94%, respectively.
Serology
Serum samples were collected from seals of various ages, including young pups, during the annual cull in May 1992. The details of the seals sampled and the anti-CDV neutralising Fig. 1 . Phylogenetic relationships between PDV-2 and the other CDV isolates. Trees were derived using the PHYLIP programmes (Felsenstein, 1989 titres are presented in Table 1 . Many of these sera showed significant neutralising titres against CDV. Since virus neutralisation can sometimes be due to other inhibitory factors in the serum, it was decided to confirm the presence of morbillivirus-specific antibodies using CDV, RPV and PPRV antigens in ELISAs. Of the fourty four Baikal seal sera tested in direct ELISA twelve showed some response with an optical density (OD) measurement twice above a negative referance sera and greater than 0.5 0D495 to CDV. A number of these sera were also found to respond when tested against RPV and PPR antigen (Fig. 3) . While there was no general correlation between virus neutralisation (VN) titres and positivity in the ELISA, six sera (56, J8, JlS,J30, J36, J43) with high VN titres were strongly cross reactive to all the morbilliviruses tested and titrated down to > 160 with the least cross-reactive antigen. The other strong positives, except 544, titrated down to 1:40 or greater with the RPV antigen. The age and weight of the seals bore no relationship to the presence of CDV specific antibodies.
During the initial epizootics in 1987/ 1988 similar ELISAs showed distinct differences in reactivity with sera from European and Siberian seals, confirming the non-identity of the two morbilliviruses (Barrett et al., 1992) . The PDV-1 sera from Europe consistently reacted more strongly with rinderpest virus (RPV) and peste des petits ruminants virus (PPRV) antigens, while sera from Baikal seals always reacted most strongly with CDV antigen. For comparison positive and negative sera (Pl-P3) from the European 1988 epizootic were also included and these reacted more strongly with RRPV and RPV as previously found (Fig. 3) .
Discussion
The sequence studies described here clearly show that the Siberian morbillivitus isolate (PDV-2) most closely resembles recent European isolates of CDV from dog and ferret. The variation in sequence from the vaccine strains (Onderstepoort and Convac) is probably due changes in the virus since the isolation of the vaccine strains in the 1950s while the vaccines have remained stable because they have been continuously passaged in tissue culture. Adaptation to growth in tissue culture and embryonated eggs to produce the attenuated vaccine is unlikely to have changed the sequence to any great extent since, in the case of the rinderpest vaccine, five of the six genes so far compared are > 99% identical to the virulent parent virus which was originally isolated in 1911 (Baron et al., 1993; Baron et al., 1994; Baron and Barrett, 1995) . Similarly in the case of vesicular stomatitis virus, the nucleotide sequence remains constant when grown for many passages at low multiplicity in tissue culture cells (Holland et al., 1979) . In contrast, sequence variation is evident in field isolates of many viruses: MV isolates from different geographical areas can be distinguished (Taylor et al., 1990 ) and the same is true for RPV isolates (Chamberlain et al., 1994) .
CDV is known to infect a wide variety of carnivore species and its effect in wildlife populations can be devastating (Appel, 1987; Carpenter et al., 1976) . However, until the identification of phocid distemper virus (PDV-1) as the cause of the seal deaths in Northern Europe in 1988, no morbillivirus had been isolated from an aquatic mammal. It was possible, therefore, that either wild type CDV or a vaccine strain of the virus used widely in domestic Table 1 LV. Mamaev et al. / Veterinav Microbiology 44 (1995) and farm animals (e.g. dog, mink and ferret) might have been responsible for the outbreak in the seals in Europe and Siberia. It is now firmly established that PDV-1 is a newly described virus of seals and it is probable that PDV-1 has been circulating for a considerable time in some unknown seal population, probably in the North Atlantic and Arctic Sea, before its isolation in 1988 (see Barrett et al., 1992 and Duignan et al., 1995) . One likely explanation for the spread of the virus to European seals was the large-scale migration of harp seals from the Barents Sea to northern Europe in 19861987 (Dietz et al., 1989) . Lake Baikal has no direct connection with this source of infection but it is probable that the seals there are susceptible to infection with PDV-1. The epizootic in Baikal seals was most probably caused by contact with terrestrial carnivores infected with CDV. Such outbreaks of CDV are common in wild carnivores and domestic dogs around Lake Baikal. It is highly unlikely that any of the current CDV vaccines were responsible for the epizootic in Baikal seals, however, since they are not attenuated for wild life species it is possible that the vaccines could be capable of causing disease in Siberian seals. It appears that these viruses can readily pass between the terrestrial and aquatic environments; there is evidence that the European seal virus PDV-1 caused an infection at a mink farm near the sea in Denmark (Blixenkrone-Moller et al., 1989 and Blixenkrone-M#ller et al., 1990) and CDV has been isolated from a captive seal in Canada (Lyons et al., 1993) . The evidence that the virus remained in the Baikal seals after 1988 is disturbing, but it may be that the virus has always circulated in that population and was only recognised in 1988 because the molecular techniques were available to enable us to recognise it. It is necessary to study the epizootiology of these virus diseases in wild animal populations so that the pattern of interspecies infection can be understood and the risks to small endangered species carefully assessed. n RPV Cl PPRV
